Previous 10 | Next 10 |
Image source: The Motley Fool. Reata Pharmaceuticals, Inc. (NASDAQ: RETA) Q4 2019 Earnings Call Feb 19, 2020 , 4:30 p.m. ET Operator Continue reading
Reata Pharmaceuticals, Inc (RETA) Q4 2019 Earnings Conference Call February 19, 2020 04:30 PM ET Company Participants Vinny Jindal - Vice President of Strategy Warren Huff - Chief Executive Officer Colin Meyer - Chief Medical Officer Manmeet Soni - Chief Financial Officer Co...
Reata Pharmaceuticals (NASDAQ: RETA ): Q4 Non-GAAP EPS of -$1.59; GAAP EPS of -$5.91 misses by $0.76 . More news on: Reata Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
PLANO, Texas, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” or “we”), a clinical-stage biopharmaceutical company, today announced financial results for the fourth quarter and full year ended De...
Reata Pharmaceuticals (NASDAQ: RETA ) is scheduled to announce Q4 earnings results on Wednesday, February 19th, after market close. The consensus EPS Estimate is -$3.90 vs. -$0.86 in 4Q18 and the consensus Revenue Estimate is $6.66M (-21.2% Y/Y). Over the last 1 year, RETA h...
PLANO, Texas, Feb. 12, 2020 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today announced that it will report financial results and provide an update on recent progress on its development programs post-market on February 19, 2020...
Healthcare Pulse The market doesn't like uncertainty. And when you think about healthcare, that uncertainty is immediately magnified. Fundamentally, healthcare couldn't be better positioned, with an aging America, rapidly advancing therapies, a faster-moving FDA, easy access to risk capi...
Reata Pharmaceuticals ( RETA +10.9% ) is up out the gate on reports that Amgen ( AMGN -3.9% ) is mulling acquiring assets in the space. More news on: Reata Pharmaceuticals, Inc., Amgen Inc., Healthcare stocks news, Stocks on the move, Merger & acquisition news, Read more ...
Source: GraycellAdvisors.com Systematic Investing Systematic investing has become a growing part of the stock market. The investing style refers to a rules-based algorithmic system that limits or eliminates individual judgments and biases towards portfolio selection and adjustments. ...
Biotech Pulse The biotech group closed 2019 with its longest rally of the year. It was a welcome change from what had mostly been an uphill battle. While the broader market was sailing from one high to another, biotechs and pharmaceuticals (biopharma) were still marking their 2019 lows in ea...
News, Short Squeeze, Breakout and More Instantly...
Reata Pharmaceuticals Inc. Company Name:
RETA Stock Symbol:
NASDAQ Market:
Reata Pharmaceuticals Inc. Website:
According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2...
Laser Photonics Corporation (LASE) is expected to report for Q2 2024 QuickLogic Corporation (QUIK) is expected to report $0.08 for Q3 2023 Stryve Foods Inc. (SNAX) is expected to report $-1.65 for Q3 2023 Reata Pharmaceuticals Inc. (RETA) is expected to report $-2.15 for Q3 2023 V...
Reata Pharmaceuticals Inc. (RETA) is expected to report $-2.15 for Q3 2023